Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 19, 2021 - Issue 6
Submit an article Journal homepage
167
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Staphylococcus aureus antimicrobial susceptibility trends and cluster detection in Vermont: 2012-2018

John Stellinga Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USA;b Department of Medicine, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5719-7754View further author information
ORCID Icon,
Jennifer S. Readc Infectious Disease Epidemiology Division, Vermont Department of Health, Burlington, VT, USA;d Department of Pediatrics, University of Vermont Medical Center, Burlington, VT, USAView further author information
,
Rob Petersa Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USAView further author information
,
Adam Clarka Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-4090-7232View further author information
ORCID Icon,
Marissa Bokharia Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USAView further author information
&
Thomas F. O’Briena Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USA;b Department of Medicine, Harvard Medical School, Boston, MA, USAView further author information
Pages 777-785 | Received 16 Jul 2020, Accepted 30 Oct 2020, Published online: 08 Jan 2021

References

  • CDC/CSTE/APHL Antimicrobial Resistance Surveillance Task Force. Antimicrobial resistance surveillance task force, Year 2. Report and recommendation for antimicrobial resistance surveillance in the United States. Atlanta, Georgia; 2018 Sep [cited 2020 Oct 8]. Available from: https://cdn.ymaws.com/www.cste.org/resource/resmgr/arstf/ARSTF_Year_2_Report_and_Reco.pdf
  • Klevens RM, Morrison MA, Nadle J, et al. the Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct 17;298(15):1763–1771.
  • Bancroft EA. Antimicrobial resistance: it’s not just for hospitals [editorial]. JAMA. 2007;298:803–804.
  • Centers for Disease Control and Prevention. National healthcare safety network multidrug-resistant organism & clostridium difficile infection (MDRO/CDI) module. Atlanta, Georgia; 2019 Jan [cited 2020 Oct 8]. Available from: www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf
  • Stelling JM, Read JS, Fritch W, et al. Surveillance of antimicrobial resistance and evolving microbial populations in Vermont: 2011-2018. Expert Rev Anti Infect Ther. 2020 Jun 18(10):1055-1062.
  • WHONET Home Page; [ cited 2020 Oct 8]. Available from: www.whonet.org.
  • O’Brien TF, Stelling J. Integrated multilevel surveillance of the world’s infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev. 2011;24(2):281–295.
  • O’Brien TF, Stelling J. The world’s microbiology laboratories can be a global microbial sensor network. Biomedica. 2014;34(Suppl 1):9–15.
  • RStudio Team. RStudio: integrated development for R. PBC, Boston: RStudio; 2020 [cited 2020 Oct 8]. Available from: www.rstudio.com
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 30th edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2020. (CLSI Supplement M100).
  • Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline – fourth edition. Wayne, Pennsylvania; 2014. (CLSI document M39-A4).
  • Huang SS, Yokoe DS, Stelling J, et al. Automated detection of infectious disease outbreaks in hospitals: a retrospective cohort study. PLoS Med. 2010;7(2):e1000238.
  • Tsutsui A, Yahara K, Clark A, et al. Automated detection of outbreaks of antimicrobial-resistant bacteria in Japan. J Hosp Infect. 2019 Jun;102(2):226–233.
  • Viñas M, Tuduri E, Galar A, et al. Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina. PLoS Negl Trop Dis. 2013;7(12):e2521.
  • Stelling J, Yih KW, Galas M, et al. Automated use of WHONET and SaTScan to detect outbreaks of Shigella spp. using antimicrobial resistance phenotypes. Epidemiol Infect. 2010;138(6):873–883.
  • SaTScan Home Page. [ cited 2020 Oct 8]. Available from: www.satscan.org.
  • Kulldorff M, Heffernan R, Hartman J, et al. A space-time permutation scan statistic for the early detection of disease outbreaks. PLoS Med. 2005;2:216–224.
  • Jung I, Kulldorff M, Richard OJ. A spatial scan statistic for multinomial data. Stat Med. 2010;29:1910–1918.
  • Baker MA, Yokoe DS, Stelling J, et al. Automated outbreak detection of hospital-associated pathogens: value to infection prevention programs. Infect Control Hosp Epidemiol. 2020 Sep(41)9:1016-1021..
  • Park R, O’Brien TF, Huang SS, et al. Centers for Disease Control and Prevention Epicenters Program. Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan. Expert Rev Anti Infect Ther. 2016 Nov;14(11):1097–1107.
  • HealthMap Resistance Open [Internet]. Boston: Boston Children’s Hospital; [ cited 2020 Oct 8]. Available from: http://resistanceopen.org/
  • Antibiotic Resistance Patient Safety Atlas (ARPSA) [Internet]. Atlanta: Centers for Disease Control and Prevention; [ cited 2020 Oct 8]. Available from: http://gis.cdc.gov/grasp/PSA/
  • Vermont Department of Health. Heroin and other opioids in Vermont; [ cited 2020 Oct 8]. Available from www.healthvermont.gov/alcohol-drugs/by-substance/heroin-and-other-opioids
  • Tron G. How did idyllic Vermont become America’s heroin capital? Politico Magazine; 2014 Feb 7 [cited 2020 Oct 8]. Available from: www.politico.com/magazine/story/2014/02/vermont-heroin-capital-of-america-103280
  • Kanjilal S, Sater MRA, Thayer M, et al. Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014. J Clin Microbiol. 2017 Dec 26;56(1). DOI:10.1128/JCM.01160-17
  • Davido B, Lawrence C, Dinh A, et al. Back to the future with the use of penicillin in Penicillin-Susceptible Staphylococcus aureus (PSSA) Bacteremia. Am J Med. 2018 Apr;131(4):e155.
  • Jokinen E, Laine J, Huttunen R, et al. Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia. Infect Dis (Lond). 2018 Jan;50(1):52–58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.